Gsa Capital Partners LLP Abiomed Inc Transaction History

Gsa Capital Partners LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $415,627 - $516,702	1,714 Added 87.14%	3,681 $904,000
Q2 2022 Aug 09, 2022	BUY	$224.73 - $338.64 $442,043 - $666,104	1,967 New	1,967 $487,000
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $957,506 - $1.18 Million	-3,185 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$310.19 - $376.2 $987,955 - $1.2 Million	3,185 New	3,185 $1.04 Million
Q2 2020 Aug 11, 2020	SELL	$141.4 - $257.09 $291,566 - $530,119	-2,062 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$130.51 - $196.01 $639,368 - $960,252	-4,899 Reduced 70.38%	2,062 $299,000
Q4 2019 Feb 12, 2020	BUY	$159.31 - $223.54 $823,473 - $1.16 Million	5,169 Added 288.45%	6,961 $1.19 Million
Q3 2019 Nov 12, 2019	SELL	$175.89 - $279.23 $199,459 - $316,646	-1,134 Reduced 38.76%	1,792 $319,000
Q2 2019 Aug 06, 2019	SELL	$250.96 - $284.94 $2.51 Million - $2.85 Million	-9,995 Reduced 77.35%	2,926 $762,000
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $3.57 Million - $4.68 Million	12,921 New	12,921 $3.69 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.